期刊文献+

血管内皮生长因子基因多态性与脑梗死的关系 被引量:2

Correlation of VEGF gene polymorphism with cerebral infarction
下载PDF
导出
摘要 目的:研究血管内皮生长因子(VEGF)基因rs1570360、rs3025039和rs699947与脑梗死是否存在相关性。方法:采用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)技术,对147例急性脑梗死患者(脑梗死组)和131例非急性脑梗死对照者(对照组)VEGF基因rs1570360、rs3025039和rs699947的多态性进行分析。结果:脑梗死组的三酰甘油(TG)、低密度脂蛋白胆固醇(LDL-C)、血糖、血压(收缩压、舒张压)明显高于对照组,而高密度脂蛋白胆固醇(HDL-C)则明显降低(P均<0.05)。脑梗死组患者VEGF rs1570360、rs3025039和rs699947基因型频率和等位基因频率与对照组比较,差异无统计学意义(P>0.05)。脑梗死危险因素的多元逐步Logistic回归分析显示,TG、血糖和收缩压是脑梗死的独立危险因素。然而,脑梗死组患者VEGF rs1570360、rs3025039和rs699947的单倍型ACC(5.85%)明显低于对照组(14.22%)。结论:rs1570360、rs3025039和rs699947的单倍型ACC与脑梗死的发病可能有一定的关系。 Objective To study whether vascular endothelial growth factor(VEGF)gene polymorphism has correlation with the risk of cerebral infarction.Methods PCR-RFLP was used to analyze the polymorphism of VEGF gene rs1570360,rs3025039 and rs699947 in 147 cases of acute cerebral infarction and 131 cases of non-cerebral infarction control.Results TG,LDL-C,blood glucose,blood pressure(systolic and diastolic pressure) were obviously higher in cerebral infarction group than those in control group,and HDL-C was obviously lower(P0.05).There was no significant difference in allele and genotype distributions of rs1570360,rs3025039 and rs699947 between cerebral infarction group and control group(P0.05).Multi-step logistic regression analysis of cerebral infarction risk factor showed that TG,blood glucose and systolic pressure were the independent risk factor,however,haplotype ACC of rs1570360,rs3025039 and rs699947(5.85%) in cerebral infarction group was obviously lower than that in control group(14.22%).Conclusions Haplotype ACC of rs1570360,rs3025039 and rs699947 might have some correlation with the risk of cerebral infarction.
出处 《诊断学理论与实践》 2010年第6期560-565,共6页 Journal of Diagnostics Concepts & Practice
关键词 脑梗死 血管内皮生长因子 单核苷酸多态性 单倍型 Cerebral infarction Vascular endothelial growth factor Single nucleotide polymorphism Haplotype
  • 相关文献

二级参考文献16

  • 1倪培华,应雅韵,张洁,金磊.肝脂酶启动子250 G/A多态性与血脂的关系[J].检验医学,2005,20(6):565-570. 被引量:16
  • 2朱立红,倪培华,应雅韵,张洁,金磊,樊绮诗.血脂与肝脂酶启动子514C/T多态性的关系[J].诊断学理论与实践,2005,4(6):439-443. 被引量:10
  • 3张蕾,倪培华,应雅韵,金磊,张洁.高三酰甘油血症与肝脂酶启动子710T/C多态性的关系[J].检验医学,2006,21(3):210-214. 被引量:6
  • 4张蕾,倪培华,傅毅,应雅韵,陆国强.肝脂酶基因-250G/A多态性与脑梗死[J].诊断学理论与实践,2006,5(3):239-242. 被引量:5
  • 5施金俏,倪培华,郑寿贵,俞北伟,应雅韵,周益琴,章楠宁,范波.肝脂酶基因启动子250G/A多态性与冠心病的关系[J].中华检验医学杂志,2006,29(6):515-517. 被引量:5
  • 6National Cholesterol Education Program (NCEP) Expert Panel on Detection Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel Ⅲ). Third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel Ⅲ) final report [ J ]. Circulation, 2002, 106 (25) : 3143- 3421.
  • 7Perret B, Mabile L, Martinez L,et al. Hepatic lipase: structure/ function relationship, synthesis, and regulation [ J ]. J Lipid Res, 2002,43 ( 8 ) : 1163- 1169.
  • 8Jansen H, Chu G, Ehnholm C, et al. The T allele of the hepatic lipase promoter variant C-480T is associated with increased fasting lipids and HDL and increased preprandial and postprandial LpC re:B: European Atherosclerosis Research Study (EARS) Ⅱ[ J ]. Arterioscler Thromb Vasc Biol, 1999, 19 (2) :303-308.
  • 9Couture P, Otvos JD, Cupples LA, et al. Association of the C-514T polymorphism in the hepatic lipase gene with variations in lipoprotein subclass profiles: The Framingham Offspring Study [J].Arterioscler Thromb Vasc Biol, 2000,20 ( 3 ) : 815 -822.
  • 10Lewontin R. On measures of gametic disequilibrium. Genetics 1988; 120:849-52.

共引文献33401

同被引文献21

  • 1Yong Yong SHI,Lin HE.SHEsis,a powerful software platform for analyses of linkage disequilibrium,haplotype construction,and genetic association at polymorphism loci[J].Cell Research,2005,15(2):97-98. 被引量:382
  • 2倪培华,应雅韵,张洁,金磊.肝脂酶启动子250 G/A多态性与血脂的关系[J].检验医学,2005,20(6):565-570. 被引量:16
  • 3Primo-Parmo SL, Sorenson RC, Teiber J, et al. The hu- man serum paraoxonase/arylesterase gene (PON1) is one member of a muhigene family [J]. Genomics,1996,33(3): 498-507.
  • 4Mackness M1, Hallam SD, Peard T, et al. The separation of sheep and human serum "A"-esterase activity into the lipoprotein fraction by ultracentrifugation [J]. Comp Biochem Physiol B,1985,82(4):675-677.
  • 5Reddy ST, Wadleigh DJ, Grijalva V, et al. Human paraoxonase-3 is an HDL-associated enzyme with biolo- gical activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids[J]. Arterioscler Thromb Vasc Biol,2001,21 (4):542-547.
  • 6Draganov DI, La Du BN. Pharmacogenetics of paraoxo- nases: a brief review [J]. Naunyn Schmiedebergs Arch Pharmacol,2004,369(1):78-88.
  • 7Mackness MI, Mackness B, Durrington PN, et al. Paraoxo- nase and coronary heart disease [J]. Curt Opin Lipidol, 1998,9(4):319-324.
  • 8Gluba A, Pietrucha T, Banach M, et al. The role of poly- morphisms within paraoxonases (192 Gln/Arg in PON1 and 311Ser/Cys in PON2) in the modulation of cardiovas- cular risk: a pilot study [J]. Angiology,2010,61 (2):157-165.
  • 9Dahabreh IJ, Kitsios GD, Kent DM, et al. Paraoxonase 1 polymorphisms and ischemie stroke risk: A systematic review and meta-analysis [J]. Genet Med, 2010,12 (10): 606-615.
  • 10Banerjee I. Relationship between Paraoxonase 1 (PONI) gene polymorphisms and susceptibility of stroke: a meta- analysis[J].Eur J Epidemiol,2010,25(7):449-458.

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部